All locations are open for appointments and procedures, including COVID-19 testing. Schedule an appointment online or call your doctor’s office. Patients may be accompanied by visitors. Read our updated visitor policy.

If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Jennifer Wu, MD

NYU Langone Provider
  • Specialties: Medical Oncology, Hematology
  • Language: English

I was first drawn to medicine because I wanted to help people. I chose hematology and oncology because they are rapidly evolving fields—through their advances, I can treat people using the newest therapies. More importantly, I can care for people by forging meaningful relationships with them.

I treat each patient as a partner, and together, we work toward a common goal. Communication with my patients and their caregivers is essential to providing the best care. I also prioritize providing my patients with access to clinical trials.

At Perlmutter Cancer Center, my colleagues and I approach cancer treatment as a collaboration between specialties. We offer patients the most current clinical trials and we strive to provide as much support as possible for patients and families during such a difficult time.

My clinical and research interest is gastrointestinal cancers, with a focus on liver and biliary cancer, pancreatic cancer, and gastric cancer. Currently, I am studying whether radiation therapy in combination with immunotherapy is an effective treatment for pancreatic cancer.

Conditions and Treatments

  • gastrointestinal cancer
  • colon cancer
  • rectal cancer
  • pancreatic cancer
  • esophageal cancer
  • stomach cancer
  • anal cancer
  • gallbladder cancer
  • biliary cancer
  • liver cancer
  • colorectal cancer
  • abdominal tumor

Board Certifications
  • American Board of Internal Medicine (Hematology), 2007
  • American Board of Internal Medicine (Medical Oncology), 2006
  • American Board of Internal Medicine - Internal Medicine, 2003
Education and Training
  • Fellowship, NYU Medical Center, Hematology/Oncology, 2006
  • Fellowship, NYU Medical Center, Hematology/Oncology, 2004
  • MD from Albert Einstein College of Med, 2000

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

  • A Phase 1 Parallel Open-Label Study of the Safety and Tolerability Pharmacokinetics and Antileukemic Activity of ASTX660 as a Single Agent and in Combination with ASTX727 in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

    Learn More
  • A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

    Learn More
  • A Phase 2 Randomized Double-blind Study of Glutaminase Inhibitor Telaglenastat with Pembrolizumab and Chemotherapy vs Placebo with Pembrolizumab and Chemotherapy in Front-line Metastatic KEAP1/NRF2- mutated Nonsquamous Non-Small Cell Lung (NSCLC)

    Learn More
View All Research Studies (26)

Read All Publications (30)